Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BD Contoured Base Pen Needle

K-Number: K182320 · 2018-12-20

Decision Date2018-12-20
Product CodeFMI
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

BD Contoured Base Pen Needle is a medical device manufactured by Becton, Dickinson and Company. It received FDA 510(k) clearance on 2018-12-20 under approval number K182320. The device is classified under product code FMI. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BD Contoured Base Pen Needle?

BD Contoured Base Pen Needle is a medical device that received FDA 510(k) clearance on 2018-12-20. It is manufactured by Becton, Dickinson and Company. The 510(k) number is K182320.

When was BD Contoured Base Pen Needle approved by the FDA?

BD Contoured Base Pen Needle received FDA 510(k) clearance on 2018-12-20, under approval number K182320.

What company makes BD Contoured Base Pen Needle?

BD Contoured Base Pen Needle is manufactured by Becton, Dickinson and Company.

What is the FDA product code for BD Contoured Base Pen Needle?

The FDA product code for BD Contoured Base Pen Needle is FMI.

Other Devices by Becton, Dickinson and Company

View all 100 devices →

Related Devices (Code: FMI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.